Catalyst Funds Management Pty Ltd

Position in VCYT — Veracyte, Inc.

CIK 1896150 SYDNEY NSW, C3

Position in VCYT

as of Mar 31, 2026 · filed May 11, 2026 Compact

Position Value

$280,227

+$48,677 QoQ

Shares Held

8,700

+58.2% QoQ

Ownership

0.011%

of shares outstanding

% of Portfolio

0.05%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2024

6 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Catalyst Funds Management Pty Ltd holds $1,479,733 across 6 Diagnostics & Research names. VCYT ranks #2 (18.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MEDP	Medpace Holdings, Inc.	1,040	$499,397
2	VCYT	Veracyte, Inc. This page	8,700	$280,227
3	WAT	Waters Corp /De/	920	$273,976
4	DGX	Quest Diagnostics Inc	1,065	$208,718
5	MYGN	Myriad Genetics Inc	33,980	$152,910
6	MDXH	MDxHealth SA	28,046	$64,505

6 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$280,227	8,700	+58.2%	Shares	Sole	2026-05-11
2025-12-31	$231,550	5,500	-16.7%	Shares	Sole	2026-02-09
2025-09-30	$226,578	6,600	-46.3%	Shares	Sole	2025-11-12
2025-06-30	$332,469	12,300	+515.0%	Shares	Sole	2025-08-12
2024-06-30	$43,340	2,000	+185.7%	Shares	Sole	2024-12-18
2024-03-31	$15,512	700	—	Shares	Sole	2024-12-05
No filing history on record for this holder in this stock.